New Frontiers in Interventional Cardiology 2013 – Highlights from the biggest workshop in Central and Eastern Europe
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 5
Abstract
Since 1999, at the end of each year, cardiologists, interventional cardiologists and cardiac surgeons from all over the World meet in Cracow to discuss the most challanging topics in recent cardiology. From the beginning the workshop directors who organize this event are – prof. Dariusz Dudek, prof. Krzysztof Żmudka and assoc. prof. Jacek Legutko. This year, between the 27th and 30th of November 2013, ca. 1200 participants visited the most important workshop on Interventional cardiology in Central and Eastern Europe. This years‘ event was held under the auspices of the Rector of the Jagiellonian University – prof. Wojciech Nowak and the Marshal of the Małopolska voivodeship – Mr Marek Sowa.
Authors and Affiliations
Jakub Podolec
Keywords
Related Articles
- EP ID EP248129
- DOI 10.20418/jrcd.vol1no5.133
- Views 83
- Downloads 0
Cardiopulmonary exercise tests in rare cardiovascular heart diseases
Cardiopulmonary exercise testing (CPET) is commonly used in clinica practice for both functional and diagnostic assessments of patients with cardiovascular and pulmonary disease. It provides assessment of the integrative...
A rare cardiac manifestation of Brucellosis (RCD code: VIII)
Brucellosis, a zoonosis caused by gram negative bacillus Brucella, is characterized by a systemic illness with vague symptoms. Though, cardiac involvement with Brucella is reported mostly as endocarditis, the occurrence...
Common problems in rare congenital heart diseases
Congenital heart disease (CHD) is the most common developmental anomaly and is found in about 1% of all live-born children.Recent progress in cardiac surgery and pediatric cardiology hasresulted in large numbers of adult...
Establishing the optimal dose of nitric oxide in acute vasoreactivity testing in patients with pulmonary hypertension with use of the Bronchial Control Treatment System (RCD code: II)
The key point in the diagnostic algorithm for pulmonary hypertension plays the pulmonary reactivity testing, the agent most frequently used in the test is inhaled nitric oxide (iNO). Various dosages of iNO were used in a...
Successful reversal of advanced heart failure due to peripartum cardiomyopathy with aggressive pharmacotherapy and a continuous‑flow left ventricular assist device (RCD code: III-1B.8c)
Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy. PPCM is not well understood and relatively little is known about its epidemiology and pathogenesis. However, it appears to...